Investor Stock List
Ranked #1,014 of 8,699 institutional investors

Vestal Point Capital, LP

New York, NY

$3.56B
US stock portfolio at live prices · today −$57.0M (−1.58%)
Live prices, last trade 11:13 AM ET
Value at quarter end (Q3 2026)
$3.87B
Change from Q2 2026
−$408.7M (−9.55%)
Positions
56 · 13 new, 16 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$329M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
INSM 11.2%NBIX 10.8%BMRN 9.50%ABVX 7.86%UTHR 7.39%
StockSharesValue, live% of portfoliovs Q2 2026
INSM Insmed Incorporated2,725,000$400M11.2%Added +990%
NBIX Neurocrine Biosciences, Inc.2,500,000$385M10.8%Added +33%
BMRN BioMarin Pharmaceutical Inc.5,525,000$338M9.50%Reduced −8%
ABVX ABIVAX Société Anonyme3,960,000$280M7.86%Added +69%
UTHR United Therapeutics Corporation475,000$263M7.39%Added +9%
ARWR Arrowhead Pharmaceuticals, Inc.4,815,000$207M5.82%Added +206%
TARS Tarsus Pharmaceuticals, Inc.2,033,625$153M4.29%Added +94%
ELVN Enliven Therapeutics, Inc.3,225,000$152M4.26%Reduced −19%
IRON Disc Medicine, Inc.1,635,000$122M3.43%Added +5%
DYN Dyne Therapeutics, Inc.6,200,000$99.5M2.79%Added +84%
NRIX Nurix Therapeutics, Inc.7,025,000$93.2M2.62%Reduced −13%
TSHA Taysha Gene Therapies, Inc.18,045,000$68.0M1.91%Reduced −7%
GMED Globus Medical, Inc.915,000$62.3M1.75%Added +8%
GLUE Monte Rosa Therapeutics, Inc.7,130,000$62.2M1.75%Added +55%
BCAX Bicara Therapeutics Inc.5,525,000$49.7M1.40%Added +5%
ZBH Zimmer Biomet Holdings, Inc.475,000$48.5M1.36%Reduced −66%
XENE Xenon Pharmaceuticals Inc.850,000$31.8M0.89%Added +21%
BBIO BridgeBio Pharma, Inc.400,000$30.9M0.87%New
TVTX Travere Therapeutics, Inc.600,000$29.0M0.81%New
PODD Insulet Corporation175,000$24.4M0.68%Reduced −74%
SNY Sanofi500,000$23.3M0.65%Reduced −75%
IMCR Immunocore Holdings plc850,000$22.6M0.64%Reduced −53%
RCUS Arcus Biosciences, Inc.1,300,000$20.9M0.59%New
TRVI Trevi Therapeutics, Inc.1,495,000$20.1M0.56%Reduced −52%
SGP SpyGlass Pharma, Inc.640,000$20.0M0.56%Reduced −4%
ZYME Zymeworks Inc.600,000$16.4M0.46%New
NKTR Nektar Therapeutics510,000$16.1M0.45%Reduced −49%
SVRA Savara Inc.3,300,000$14.2M0.40%Added +21%
LXEO Lexeo Therapeutics, Inc.4,320,000$13.6M0.38%Unchanged
SLDB Solid Biosciences Inc.2,085,000$13.3M0.37%Reduced −3%
COGT Cogent Biosciences, Inc.475,000$12.9M0.36%New
DRUG Bright Minds Biosciences Inc.545,000$11.6M0.32%Unchanged
GKOS Glaukos Corporation45,000$10.8M0.30%New
ZBIO Zenas BioPharma, Inc.395,000$10.1M0.28%Added +8%
KRSA Korsana Biosciences, Inc.263,105$9.9M0.28%New
STOK Stoke Therapeutics, Inc.345,000$9.4M0.27%New
EVMN Evommune Inc1,250,000$8.8M0.25%Added +25%
TECX Tectonic Therapeutic, Inc.360,000$7.6M0.21%Reduced −15%
VKTX Viking Therapeutics, Inc.290,000$7.4M0.21%Reduced −57%
KLRA Kailera Therapeutics, Inc.625,000$7.3M0.20%Added +9%
TRAX First Tracks Biotherapeutics, Inc.169,738$7.1M0.20%Reduced −83%
RZLT Rezolute, Inc.1,455,000$5.8M0.16%Added +280%
MLTX MoonLake Immunotherapeutics525,000$5.8M0.16%New
MAZE Maze Therapeutics, Inc.175,000$5.7M0.16%New
AVTX Avalo Therapeutics, Inc.800,000$5.5M0.15%Added +3%
AVR Anteris Technologies Global Corp.850,000$4.3M0.12%Reduced −16%
VYGR Voyager Therapeutics, Inc.2,165,000$3.5M<0.1%Reduced −18%
OLMA Olema Oncology, Inc.420,000$3.0M<0.1%Added +0%
OKUR OnKure Therapeutics, Inc.1,088,000$3.0M<0.1%Reduced −40%
ENGN enGene Therapeutics Inc.1,665,000$3.0M<0.1%Reduced −0%
NGNE Neurogene Inc.115,000$2.6M<0.1%New
PALI Palisade Bio, Inc.2,500,000$2.4M<0.1%Unchanged
IBIO iBio, Inc.2,600,000$2.1M<0.1%Unchanged
AVBP ArriVent BioPharma, Inc.100,000$1.1M<0.1%New
CTMX CytomX Therapeutics, Inc.535,000$1.1M<0.1%New
APRE Aprea Therapeutics, Inc.350,000$96K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ABT Abbott Laboratories1,400,000$146M
RVMD Revolution Medicines, Inc.450,000$74.5M
RGEN Repligen Corporation400,000$66.9M
BCRX BioCryst Pharmaceuticals, Inc.8,300,000$60.8M
BMY Bristol-Myers Squibb Company800,000$47.4M
REGN Regeneron Pharmaceuticals, Inc.40,000$37.3M
GEHC GE HealthCare Technologies Inc.450,000$36.7M
MYGN Myriad Genetics, Inc.5,735,000$31.6M
MDGL Madrigal Pharmaceuticals, Inc.65,000$25.4M
BBNX Beta Bionics, Inc.1,600,000$21.9M
ANRO Alto Neuroscience Inc785,000$19.9M
RAPP Rapport Therapeutics, Inc.730,000$17.2M
SRZN Surrozen, Inc.304,669$9.1M
MNPR Monopar Therapeutics Inc.75,727$5.2M
SGMT Sagimet Biosciences Inc.535,452$4.9M
TENX Tenax Therapeutics, Inc.53,439$69K